🇺🇸 FDA
Patent

US 9043996

Genetically modified major histocompatibility complex animals

granted A61KA61K39/00

Quick answer

US patent 9043996 (Genetically modified major histocompatibility complex animals) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K39/00